E
ZyVersa Therapeutics, Inc. ZVSA
$0.7899 -$0.0111-1.39%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -21.33M -21.83M -97.58M -98.30M -89.64M
Total Depreciation and Amortization -98.80K 18.20K 10.40K 10.40K 126.50K
Total Amortization of Deferred Charges -- -- -- -- 0.00
Total Other Non-Cash Items 12.70M 12.69M 87.62M 86.97M 74.88M
Change in Net Operating Assets -391.90K -288.40K 2.04M 2.60M 4.89M
Cash from Operations -9.12M -9.41M -7.91M -8.72M -9.74M
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 8.50M 10.74M 21.75M 19.08M 14.08M
Repurchase of Common Stock 0.00 0.00 -7.20K -7.20K -7.20K
Issuance of Preferred Stock -- -- -- -- 548.80K
Repurchase of Preferred Stock 0.00 -230.00K -10.70M -10.70M -10.70M
Total Dividends Paid -- -- -- -- --
Other Financing Activities -833.60K -1.20M -2.39M -2.42M -1.81M
Cash from Financing 7.67M 9.31M 8.66M 5.96M 2.12M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- 0.00 0.00 0.00 0.00
Net Change in Cash -1.46M -109.20K 755.50K -2.76M -7.62M
Weiss Ratings